Not yet reviewed — this article is pending editorial review by Lyrea.
Citation noticeOur citation system is being overhauled
References and citation markers may currently be incomplete, mismatched, or incorrect. This system is being rebuilt and reviewed before the full site launch.
Mdpa
MDPA is an obscure substituted methylenedioxyphenethylamine with little history of human use. It is classified as an empathogen and research chemical. Its pharmacological profile is largely unknown, though it is suspected to share properties with other MDxx compounds, potentially acting as a monoamine releaser, a reuptake inhibitor, or both. It is described as habit-forming.
Dosage & Duration
Dosage
Doses are population estimates that vary widely between individuals.
Duration
Subjective Effects
Legacy content. A statistically backed ontology from Mindstate Design Labs is coming soon.
Little is documented about the subjective experience of this compound, which has almost no history of human use. Its pharmacological profile is largely unknown, and no reliable first-hand accounts of its effects are available.
Pharmacology
Pharmacodynamics
The pharmacological profile of MDPA is largely uncharacterized. Based on its structural relationship to other MDxx compounds, it is suspected of sharing similar properties, most likely acting as a monoamine releasing agent, a monoamine reuptake inhibitor, or both. No receptor binding or functional activity data is available.
Pharmacokinetics
Interactions
An unlisted combination is an unknown one, not a safe one. Check a dedicated combination chart before mixing.
Tolerance
Harm Potential
History & Culture
MDPA remained an obscure substituted methylenedioxyphenethylamine with little documented history of human use, and its pharmacological profile stayed largely uncharacterized.
Legality
Article Status
Step 1 · Automated synthesisAn autonomous workflow built by Josie Kins compiled this article's foundation from information published across the web.
- Step 2 · First-pass reviewPending
Not yet reviewed — this article is pending editorial review by Lyrea.
- Step 3 · Citation reviewPending
No one has reviewed this article's citations yet. That second pass checks each claim against the source it cites.
Recent changes7 human edits · latest
Times are UTCNewest first
24 January 2026
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Josie Kins · Updated the article · also 1,4-Butanediol, 1B-LSD, 1cP-AL-LAD and 573 more
Suggest an edit
Spotted a mistake, an outdated claim, or something missing from the Mdpa article? Send the editors a private note. Feedback lands in a moderation queue and is never shown on the site.
Wish to give generalised feedback? You can do so here.